Hip Reconstruction Devices Market Is Anticipated to Climb to A Size of US$ 12.15 Billion by 2033

Expanding at a steady CAGR of 4%, the global hip reconstruction devices market is valued at US$ 8.21 billion in 2023 and is projected to reach US$ 12.15 billion by the year 2033. Hip reconstruction devices are bifurcated into primary hip reconstruction devices, partial hip reconstruction devices, revision hip reconstruction devices, and hip resurfacing devices. Sales of primary hip reconstruction devices are expected to progress at a CAGR of 4.5% during the forecast period.

Primary hip reconstruction is a clinical intervention where a primary joint replacement procedure is carried out on the specific injured joint of the patient. A damaged or worn-out hip joint is replaced using implants made of metal, high-density polyethylene, or ceramic during a primary hip replacement surgery.

𝗗𝗼𝘄𝗻𝗹𝗼𝗮𝗱 𝗮 𝗦𝗮𝗺𝗽𝗹𝗲 𝗖𝗼𝗽𝘆 𝗼𝗳 𝗧𝗵𝗶𝘀 𝗥𝗲𝗽𝗼𝗿𝘁:https://www.factmr.com/connectus/sample?flag=S&rep_id=8249?PJ

"𝗜𝗻𝗰𝗿𝗲𝗮𝘀𝗶𝗻𝗴 𝗦𝗲𝗻𝗶𝗼𝗿 𝗣𝗼𝗽𝘂𝗹𝗮𝘁𝗶𝗼𝗻 𝗮𝗻𝗱 𝗣𝗿𝗲𝘀𝗲𝗻𝗰𝗲 𝗼𝗳 𝗟𝗲𝗮𝗱𝗶𝗻𝗴 𝗛𝗶𝗽 𝗥𝗲𝗰𝗼𝗻𝘀𝘁𝗿𝘂𝗰𝘁𝗶𝗼𝗻 𝗗𝗲𝘃𝗶𝗰𝗲 𝗠𝗮𝗻𝘂𝗳𝗮𝗰𝘁𝘂𝗿𝗲𝗿𝘀"

The United States is currently dominating the North American hip reconstruction devices market. This dominance can be attributed to the factors such as the rising rate of the senior population in the nation, the high prevalence of hip fractures and arthritis, and the presence of well-established healthcare infrastructure and key market players.

Additional factors anticipated to boost market growth include advantageous government healthcare policies and the rising number of research partnerships.

𝗞𝗲𝘆 𝗖𝗼𝗺𝗽𝗮𝗻𝗶𝗲𝘀 𝗣𝗿𝗼𝗳𝗶𝗹𝗲𝗱

B. Braun Melsungen AG
Corin Group PLC
DePuy Synthes
Exactech, Inc.
MicroPort Scientific Corporation
Smith & Nephew PLC
Stryker Corporation
United Orthopedic Corporation
Waldemar Link GmbH & Co. KG
Zimmer Biomet Holdings, Inc.

𝗠𝗮𝗿𝗸𝗲𝘁 𝗗𝘆𝗻𝗮𝗺𝗶𝗰𝘀

The hip reconstruction devices market is influenced by several key factors that shape its growth and evolution:

1. Aging Population and Increased Longevity: The global aging population contributes significantly to the demand for hip reconstruction devices. As individuals age, the incidence of hip-related conditions such as osteoarthritis and fractures increases, driving the need for hip joint interventions.

2. Technological Advancements: Continuous advancements in materials, implant design, and surgical techniques enhance the effectiveness and longevity of hip reconstruction devices. Minimally invasive procedures, computer-assisted navigation, and improved biomaterials contribute to positive patient outcomes.

3. Growing Prevalence of Hip Disorders: The rising prevalence of hip disorders, including degenerative joint diseases and traumatic injuries, is a key driver for the hip reconstruction devices market. These conditions often necessitate surgical interventions for joint restoration.

4. Patient Preference for Active Lifestyles: Increasing awareness of the benefits of hip reconstruction procedures and a growing desire among patients to maintain an active lifestyle contribute to the demand for effective and durable hip implants.

𝗥𝗲𝗰𝗲𝗻𝘁 𝗗𝗲𝘃𝗲𝗹𝗼𝗽𝗺𝗲𝗻𝘁𝘀

The hip reconstruction devices market has experienced notable developments in recent years, reflecting advancements in technology and evolving patient needs:

Personalized Implants and 3D Printing: The adoption of 3D printing technology allows for the creation of personalized hip implants tailored to an individual's anatomy. This approach enhances implant fit, reduces complications, and contributes to improved patient satisfaction.

Enhanced Biomaterials for Longer Lifespan: Manufacturers are investing in the development of advanced biomaterials for hip implants, aiming to extend the lifespan of devices. Improved wear resistance and durability address concerns related to implant longevity and the need for revision surgeries.

Robot-Assisted Hip Replacement Surgery: The integration of robotic-assisted surgery in hip reconstruction has gained momentum. Robotic systems assist surgeons in achieving greater precision and accuracy during procedures, leading to improved outcomes and reduced recovery times.

Dual Mobility Implants: Dual mobility hip implants, designed to reduce the risk of dislocation, have gained popularity. These implants incorporate an additional articulating surface, providing enhanced stability and reducing the likelihood of implant-related complications.

Outpatient and Rapid Recovery Protocols: Advances in surgical techniques and postoperative care have facilitated the adoption of outpatient hip replacement procedures and rapid recovery protocols. These approaches aim to minimize hospital stays and accelerate the rehabilitation process.

𝗖𝗼𝗺𝗽𝗲𝘁𝗶𝘁𝗶𝘃𝗲 𝗟𝗮𝗻𝗱𝘀𝗰𝗮𝗽𝗲

Global leaders in terms of market revenue are Zimmer Biomet, DePuy Synthes, and Stryker Corporation. Zimmer Biomet holds the largest market share due to increasing sales of its hip implants. On the other side, DePuy Synthes and Stryker are in the top positions as a result of their strong sales forces, superior local supply capabilities, and attention to both organic and inorganic growth strategies.

The ROSA Hip System for robotically-assisted direct anterior total hip replacement has been approved by the U.S. Food and Drug Administration (FDA), according to a statement issued by Zimmer Biomet Holdings, Inc. in August 2021.

𝗚𝗲𝘁 𝗖𝘂𝘀𝘁𝗼𝗺𝗶𝘇𝗮𝘁𝗶𝗼𝗻 𝗼𝗻 𝘁𝗵𝗶𝘀 𝗥𝗲𝗽𝗼𝗿𝘁 𝗳𝗼𝗿 𝗦𝗽𝗲𝗰𝗶𝗳𝗶𝗰 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗦𝗼𝗹𝘂𝘁𝗶𝗼𝗻𝘀:
https://www.factmr.com/connectus/sample?flag=RC&rep_id=8249

𝗦𝗲𝗴𝗺𝗲𝗻𝘁𝗮𝘁𝗶𝗼𝗻 𝗼𝗳 𝗛𝗶𝗽 𝗥𝗲𝗰𝗼𝗻𝘀𝘁𝗿𝘂𝗰𝘁𝗶𝗼𝗻 𝗗𝗲𝘃𝗶𝗰𝗲𝘀 𝗜𝗻𝗱𝘂𝘀𝘁𝗿𝘆 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵

𝗕𝘆 𝗜𝗻𝗱𝗶𝗰𝗮𝘁𝗶𝗼𝗻 :

Osteoarthritis

Rheumatoid Arthritis

Trauma

𝗕𝘆 𝗣𝗿𝗼𝗱𝘂𝗰𝘁 :

Primary Hip Reconstruction Devices

Partial Hip Reconstruction Devices

Revision Hip Reconstruction Devices

Hip Resurfacing Devices

𝗕𝘆 𝗠𝗮𝘁𝗲𝗿𝗶𝗮𝗹 :

Metal-on-metal

Metal-on-polyethylene

Ceramic-on-polyethylene

Ceramic-on-metal

Ceramic-on-ceramic

𝗕𝘆 𝗘𝗻𝗱 𝗨𝘀𝗲𝗿 :

Hospitals

Orthopedic Clinics

Ambulatory Surgical Centers

𝗕𝘆 𝗥𝗲𝗴𝗶𝗼𝗻 :

North America

Latin America

Europe

East Asia

South Asia & Oceania

MEA

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E Mail : sales@factmr.com

Fact.MR is a market research and consulting agency with deep expertise in emerging market intelligence. Spanning a wide range - from automotive & industry 4.0 to healthcare, technology, chemical and materials, to even the most niche categories.

This release was published on openPR.